InBody

InBody develops professional-grade body composition analyzers that measure muscle, fat, and water distribution across five body segments using direct segmental multi-frequency bioelectrical impedance analysis. Rather than relying on population-based estimations or statistical averages, InBody devices take independent measurements of the left arm, right arm, torso, left leg, and right leg to generate high-resolution raw data. This segmental approach, combined with an 8-point tactile electrode system that ensures consistent measurement points, delivers reproducible results that correlate highly with DEXA imaging.

The company's ecosystem extends beyond hardware to include LookinBody Web, a cloud-based data management platform that has recorded over 100 million tests globally. This platform enables healthcare professionals, fitness experts, and wellness organizations to track client progress, create evidence-based treatment plans, and access detailed analytics from anywhere. InBody devices measure additional health markers including visceral fat area, phase angle (a cellular health indicator), blood pressure, and fall risk analysis, making the technology relevant across clinical, fitness, corporate wellness, and research settings.

Founded in 1996 by Dr. Kichul Cha, InBody emerged from recognition that existing body composition devices in the 1990s were inaccurate and unreliable. The company released the InBody 2.0 in 1998 as the world's first bioelectrical impedance device combining both reproducibility and accuracy. Today, InBody operates as a multinational corporation with branches and distributors across more than 80 countries, serving hospitals, fitness centers, research institutions, and corporate wellness programs.